Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» priority review
priority review
Biogen nabs speedy FDA review for controversial Alzheimer’s drug
Fierce Biotech
Fri, 08/7/20 - 11:00 am
Biogen
aducanumab
Eisai
FDA
Alzheimer's disease
priority review
Looking at a groundbreaking advance, Myovant gets a priority review at FDA
Endpoints
Mon, 06/22/20 - 11:10 am
Myovant
FDA
priority review
Relugolix
prostate cancer
Dicerna nabs speedy review voucher for leading RNAi drug
Fierce Biotech
Thu, 06/18/20 - 10:36 am
Dicerna
RNAi
priority review
nedosiran
GSK's asthma drug Nucala gets speedy review for rare blood disorder
Endpoints
Wed, 05/27/20 - 10:25 am
GSK
FDA
Nucala
hypereosinophilic syndrome
HES
priority review
Sanofi nabs speedy review of sutimlimab, aiming for a November approval
Fierce Biotech
Fri, 05/15/20 - 10:19 am
Sanofi
cold agglutinin disease
sutimlimab
FDA
priority review
BMS' Opdivo gets another lung cancer shot as FDA, EMA accept chemo combo filings
Fierce Pharma
Wed, 04/8/20 - 11:40 pm
Bristol-Myers Squibb
Opdivo
Yervoy
non-small cell lung cancer
FDA
Europe
priority review
EMA
Takeda’s ALUNBRIG gets FDA priority review for expanded indication in NSCLC
Pharmaceutical Business Review
Tue, 02/25/20 - 10:19 am
Takeda
Alunbrig
brigatinib
FDA
priority review
non-small cell lung cancer
FDA Gives BioMarin Pharmaceuticals' Hemophilia Gene Therapy Priority Review
Motley Fool
Thu, 02/20/20 - 11:41 pm
FDA
Biomarin
priority review
valrox
gene therapy
hemophilia A
FDA Grants Priority Review to Roche's Lung Cancer Drug Tecentriq
Motley Fool
Thu, 02/20/20 - 10:44 am
Roche
FDA
priority review
Tecentriq
non-squamous non-small cell lung cancer
non-small cell lung cancer
Vifor buys priority review voucher for undisclosed filing
Fierce Biotech
Tue, 02/18/20 - 10:28 am
Vifor
priority review vouchers
FDA
priority review
Jazz targets US launch of SCLC drug after FDA grants fast review
Pharmaforum
Mon, 02/17/20 - 10:21 am
PharmaMar
Jazz Pharmaceuticals
FDA
small cell lung cancer
lurbinectedin
priority review
Seattle Genetics' Experimental Breast Cancer Drug Receives Priority Review From the FDA
Motley Fool
Thu, 02/13/20 - 11:29 pm
Seattle Genetics
tucatinib
FDA
priority review
breast cancer
HER-2 postive breast cancer
Bristol-Myers' CAR-T gets priority review, mid-August PDUFA date
Fierce Biotech
Thu, 02/13/20 - 11:04 am
Bristol-Myers Squibb
FDA
lisocabtagene maraleucel
priority review
CAR-T
Deciphera nabs speedy review for GIST cancer hopeful
Fierce Biotech
Thu, 02/13/20 - 10:49 am
Deciphera Pharma
FDA
priority review
ripretinib
GIST
FDA Speeds Up Examination of 5 Drugs with Priority Review
BioSpace
Thu, 02/13/20 - 12:24 am
FDA
priority review
capmatinib
Kite Pharma
KTE-X19
Eli Lilly
selpercatinib
GSK
belantamab mafodotin
Astex
C-DEC
FDA Grants Priority Review For Kite's KTE-X19 BLA
NASDAQ
Mon, 02/10/20 - 10:27 am
Gilead Sciences
Kite Pharma
KTE-X19
priority review
FDA
mantle cell lymphoma
GSK nabs speedy review for one of its top prospects
Fierce Biotech
Tue, 01/21/20 - 11:46 am
GSK
FDA
priority review
BCMA
belantamab mafodotin
relapsed or refractory multiple myeloma
FDA Gives Clovis Oncology's Rubraca a Priority Review
Motley Fool
Wed, 01/15/20 - 11:06 pm
Clovis Oncology
Rubraca
FDA
priority review
AZ and Merck, racing against Glaxo, nab Lynparza 'priority' boost in ovarian cancer
Fierce Pharma
Mon, 01/13/20 - 11:49 pm
AstraZeneca
Merck
GSK
Lynparza
ovarian cancer
FDA
priority review
Zejula
FDA rushed to approve 48 drugs in 2019, sometimes way ahead of schedule. Could that be dangerous?
Endpoints
Fri, 01/3/20 - 10:42 am
FDA
drug approvals
priority review
Pages
« first
‹ previous
1
2
3
4
5
6
next ›
last »